PRRT2 and cancer: AKAP12 expression is down-regulated in various cancers summarized in [29] including breast cancer [37] and have been suggested as a suppressor of invasiveness in prostate cancer through inhibition of the PKC-Raff/MEK/ERK pathway as well as inhibition of VEGF-mediated neovascularization [49].